Sanofi and Innate Pharma team up on anticancer ADCs

Sanofi ($SNY) has reached out to its French neighbor Innate Pharma to collaborate on armed antibody treatments, borrowing the biotech's technology to craft new treatments for cancer and inflammatory disease. Under the deal, Sanofi will use Innate's targeting method to hone antibody treatments designed to deliver drug payloads without affecting healthy tissues. Neither side disclosed financial details. More